BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pérez-Romero K, Rodríguez RM, Amedei A, Barceló-Coblijn G, Lopez DH. Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy. Int J Mol Sci 2020;21:E5521. [PMID: 32752264 DOI: 10.3390/ijms21155521] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Gordy JT, Sandhu AK, Fessler K, Luo K, Kapoor AR, Ayeh SK, Hui Y, Schill C, Chen F, Wang T, Karanika S, Sunshine JC, Karakousis PC, Markham RB. IFNα and 5-Aza-2’-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model. Front Immunol 2023;13. [DOI: 10.3389/fimmu.2022.1074644] [Reference Citation Analysis]
2 Jungles KM, Holcomb EA, Pearson AN, Jungles KR, Bishop CR, Pierce LJ, Green MD, Speers CW. Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1022542] [Reference Citation Analysis]
3 La Manna MP, Di Liberto D, Lo Pizzo M, Mohammadnezhad L, Shekarkar Azgomi M, Salamone V, Cancila V, Vacca D, Dieli C, Maugeri R, Brunasso L, Iacopino DG, Dieli F, Caccamo N. The Abundance of Tumor-Infiltrating CD8+ Tissue Resident Memory T Lymphocytes Correlates with Patient Survival in Glioblastoma. Biomedicines 2022;10:2454. [PMID: 36289717 DOI: 10.3390/biomedicines10102454] [Reference Citation Analysis]
4 Meng J, Yu Z, Chen H, Yu X, Jiang M, Zeng XA, You J. Brucea javanica oil emulsion significantly improved the effect of anti-programmed cell death protein-1 immunotherapy. Phytomedicine 2022;107:154446. [PMID: 36182799 DOI: 10.1016/j.phymed.2022.154446] [Reference Citation Analysis]
5 Tieng FYF, Lee L, Ab Mutalib N. Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution – A role for immunotherapy. Front Immunol 2022;13:959705. [DOI: 10.3389/fimmu.2022.959705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huang J, Huo H, Lu R. A Novel Signature of Necroptosis-Associated Genes as a Potential Prognostic Tool for Head and Neck Squamous Cell Carcinoma. Front Genet 2022;13:907985. [PMID: 35754840 DOI: 10.3389/fgene.2022.907985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pandey N, Biswas D, Dutta N, Hansda A, Dutta G, Mukherjee G. Sensing Soluble Immune Checkpoint Molecules and Disease-Relevant Cytokines in Cancer: A Novel Paradigm in Disease Diagnosis and Monitoring. Front Sens 2022;3:789771. [DOI: 10.3389/fsens.2022.789771] [Reference Citation Analysis]
8 Zhang Y, Huo L, Wei Z, Tang Q, Sui H. Hotspots and Frontiers in Inflammatory Tumor Microenvironment Research: A Scientometric and Visualization Analysis. Front Pharmacol 2022;13:862585. [PMID: 35370647 DOI: 10.3389/fphar.2022.862585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Guo Y, Yang J, Ren K, Tian X, Gao H, Tian X, Zhang X, Kan Q. The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma. Front Immunol 2022;13:861525. [PMID: 35355983 DOI: 10.3389/fimmu.2022.861525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Müller-richter U, Göbeler ME, Sayehli CM, Einsele H. Perspektiven der medikamentösen Tumortherapie. Medikamentöse Tumortherapie von Kopf-Hals-Tumoren 2022. [DOI: 10.1007/978-3-662-62808-9_13] [Reference Citation Analysis]
11 Huang C, Deng M, Leng D, Leung EL, Sun B, Zheng P, Zhang XD. MIRS: an AI scoring system for predicting the prognosis and therapy of breast cancer.. [DOI: 10.1101/2021.12.16.21267775] [Reference Citation Analysis]
12 Gianni T, Leoni V, Sanapo M, Parenti F, Bressanin D, Barboni C, Zaghini A, Campadelli-Fiume G, Vannini A. Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV. Viruses 2021;13:1747. [PMID: 34578328 DOI: 10.3390/v13091747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ramos-Espinosa G, Wang Y, Brandner JM, Schneider SW, Gorzelanny C. Melanoma Associated Chitinase 3-Like 1 Promoted Endothelial Cell Activation and Immune Cell Recruitment. Int J Mol Sci 2021;22:3912. [PMID: 33920100 DOI: 10.3390/ijms22083912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]